Vendor, Washington, DC, part of Marsh & Mclennan Companies Inc.
The Avascent Group, Ltd.
UEI SCW3QLEMEN94, CAGE 52BX5
1 award and $0 obligated between May 7, 2024 and May 7, 2024, 100% under full and open competition, against 4.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| HR001122C0156Definitive Contract, May 7, 2024, Full and Open Competition After Exclusion of Sources, 4 offers | DCMA Mid-AtlanticDefense Contract Management Agency | R&D Automated Profit Incentive Determination (Rapid) STTR Phase 2NAICS 541715, PSC AC15 | $0 |
- Places of performance
- District of Columbia
- Product and service codes
- AC15 National Defense R&D Svcs; Department Of Defense - Military; R&D Facilities & Maj Equip
- Transactions
- 1 across 1 awards